300 related articles for article (PubMed ID: 16804707)
21. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
Salu P; Uvijls A; van den Brande P; Leroy BP
Doc Ophthalmol; 2010 Jun; 120(3):251-64. PubMed ID: 20397038
[TBL] [Abstract][Full Text] [Related]
22. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
Tzekov R
Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
[TBL] [Abstract][Full Text] [Related]
23. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
Browning DJ
Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
[TBL] [Abstract][Full Text] [Related]
24. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
25. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
26. Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study.
Moschos MM; Nitoda E; Chatziralli IP; Gatzioufas Z; Koutsandrea C; Kitsos G
Drug Des Devel Ther; 2015; 9():2993-9. PubMed ID: 26089648
[TBL] [Abstract][Full Text] [Related]
27. A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity.
Tsang A; Kanda P; Gottlieb C; Virgili G; Kantungane L; Coupland S
Doc Ophthalmol; 2022 Apr; 144(2):117-124. PubMed ID: 34762206
[TBL] [Abstract][Full Text] [Related]
28. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
[TBL] [Abstract][Full Text] [Related]
29. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.
Lai TY; Chan WM; Lam DS
Am J Ophthalmol; 2004 May; 137(5):826-33. PubMed ID: 15126146
[TBL] [Abstract][Full Text] [Related]
30. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
31. Validation of the colour difference plot scoring system analysis of the 103 hexagon multifocal electroretinogram in the evaluation of hydroxychloroquine retinal toxicity.
Graves GS; Adam MK; Stepien KE; Han DP
Acta Ophthalmol; 2014 Aug; 92(5):e377-81. PubMed ID: 25043791
[TBL] [Abstract][Full Text] [Related]
32. ERG findings in patients using hydroxychloroquine.
Tzekov RT; Serrato A; Marmor MF
Doc Ophthalmol; 2004 Jan; 108(1):87-97. PubMed ID: 15104171
[TBL] [Abstract][Full Text] [Related]
33. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
[TBL] [Abstract][Full Text] [Related]
34. Missing the bull's eye.
Gilbert ME; Savino PJ
Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
[TBL] [Abstract][Full Text] [Related]
35. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
36. Clinical display of mfERG data.
Marmor MF; Cabael L
Doc Ophthalmol; 2018 Aug; 137(1):63-70. PubMed ID: 30030672
[TBL] [Abstract][Full Text] [Related]
37. First and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy.
Lai TY; Lai RY; Ngai JW; Chan WM; Li H; Lam DS
Doc Ophthalmol; 2008 Jan; 116(1):29-40. PubMed ID: 17762944
[TBL] [Abstract][Full Text] [Related]
38. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
39. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine.
Penrose PJ; Tzekov RT; Sutter EE; Fu AD; Allen AW; Fung WE; Oxford KW
Retina; 2003 Aug; 23(4):503-12. PubMed ID: 12972762
[TBL] [Abstract][Full Text] [Related]
40. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.
Arslan U; Özmert E; Demirel S; Örnek F; Şermet F
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):893-908. PubMed ID: 29546474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
